ストックスクリーナーアプリを入手
0.00
100.00%
-11.80
アフターアワーズ：
12.00
12.00
+
Ekso Bionics Holdings Inc (EKSO) 最新ニュース
CHRN|Ekso Bionics Ord Shs|Price:21.500|Chg%:-1.070 - TradingKey
Smart Exoskeleton Market Size Forecast to USD 1,937.6 Million - openPR.com
ChronoScale Holdings Stock Jumps 16.68% as Company's AI Infrastructure Play Continues Wild Streak - International Business Times Australia
EKSO stock stays anchored by Ekso Bionics' rehab robotics - AD HOC NEWS
Ekso Bionics stock leans on robotics rehab model. Nasdaq listing stays in view. - ad-hoc-news.de
Ekso Bionics Holdings Inc (EKSO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Ekso Bionics Holdings Inc (EKSO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Ekso Bionics Holdings Inc (EKSO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Ekso Bionics Holdings Inc (EKSO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Ekso Bionics (EKSO) Holds Gains as Stock Tests Near-Term Resistance LevelsIchimoku Cloud - newsline.com
Ekso Bionics Holdings Stock (US2826641040): Ticker Change To ChronoScale Raises Questions For Legacy - AD HOC NEWS
Ekso Bionics (EKSO) Shows Modest Gains as Shares Approach Resistance LevelStock Buy Zone - newsline.com
Chronoscale To Divest Ekso Bionics And Focus On Cloud Business - TradingView
ChronoScale (NASDAQ: CHRN) plans Ekso divestiture to become cloud-focused - Stock Titan
Industrial Exoskeletons Market Is Going to Boom |• Ekso Bionics • SuitX • Sarcos Robotics - openPR.com
ChronoScale Corporation: Shareholders Board Members Managers and Company Profile | US1709241046 - marketscreener.com
Ekso Bionics (EKSO) Climbs 1.29% as Stock Tests Key Resistance LevelTechnical Analysis Picks - The Legal Advocate
Ekso Bionics (EKSO) Gains Ground as Shares Approach Key ResistanceFactor Timing - The Legal Advocate
CHRN - Finviz
Ekso Bionics (EKSO) Moves Higher as Stock Tests Resistance Near $12.39Zero Lag EMA - The Legal Advocate
ChronoScale Corporation (formerly Ekso Bionics) Files 8-K/A Amendment Detailing Phantom PSU Awards for Executives - Minichart
ChronoScale (CHRN) shifts executive phantom PSU payouts to stock and cash - Stock Titan
ChronoScale Corp (CHRN) director awarded 200,000 restricted shares vesting over two years - Stock Titan
ChronoScale (CHRN) director Wes Cummins granted 200,000 restricted shares in equity award - Stock Titan
[Form 4] EKSO BIONICS HOLDINGS, INC. Insider Trading Activity - Stock Titan
Richard Nottenburg awarded 200K ChronoScale (CHRN) restricted shares - Stock Titan
ChronoScale (CHRN) director awarded 200,000 restricted shares vesting over two years - Stock Titan
ChronoScale (CHRN) director receives 109,357-share equity grant in Form 4 filing - Stock Titan
Sports Exoskeleton Market to Reach USD 1,543.98 Million by 2033 - openPR.com
Ekso Bionics Holdings stock (US2826641040): Q1 2026 results and exoskeleton strategy in focus - AD HOC NEWS
ChronoScale (CHRN) director Richard Nottenburg files Form 3 with no trades - Stock Titan
ChronoScale Corp (CHRN) director reports 3.56M shares tied to incentive plan units - Stock Titan
Armistice Capital (CHRN) reports 187,151 shares, 4.99% ownership - Stock Titan
ChronoScale (CHRN) CEO and director file initial insider ownership - Stock Titan
CHRN SEC FilingsChronoScale Corp 10-K, 10-Q, 8-K Forms - Stock Titan
EKSO SEC FilingsEkso Bionics 10-K, 10-Q, 8-K Forms - Stock Titan
Ekso Bionics Holdings stock (US2826641040): Pioneering exoskeleton tech for medical and industrial u - AD HOC NEWS
Mink Brook amendment shows 0 CHRN shares held by related entities (CHRN) - Stock Titan
Walk Assist Robot Market Research Report 2026-2031: Leading firms Such as Ekso Bionics, Lifeward, Cyberdyne, Ottobock, and DIH Medical Lead the $568.81 Million Market - Yahoo Finance
TradingKey - TradingKey
Applied Digital gains control of ChronoScale (NASDAQ: EKSO) with 97.5% stake - Stock Titan
Exoskeleton News, May 2026 – Week 19 – Numerous new events and much more… - Exoskeleton Report
Applied Digital Just Spun Out ChronoScale: What CHRN Means for APLD Stock Now - TechStock²
ChronoScale names Cenly Chen CEO to drive AI compute expansion - MSN
CHRN Should I Buy - Intellectia AI
Ekso Bionics Holdings: Fundamental Analysis and Financial Ratings | EKSO | US2826444000 - marketscreener.com
ChronoScale Corporation Common Stock (CHRN) 10K Form and Latest SEC Filings 2026 - MarketBeat
ChronoScale Corporation Common Stock (CHRN) Insider Trading Activity 2026 - MarketBeat
ChronoScale Corporation Common Stock (CHRN) Stock Price, News & Analysis - MarketBeat
CHRN PE Ratio & Valuation, Is CHRN Overvalued - Intellectia AI
Ekso Bionics Holdings, Inc. Common Stock (CHRN) Stock Forecast & Price Prediction 2026–2030 - CoinCodex
ChronoScale Names Cenly Chen CEO to Lead Expansion of AI Compute Infrastructure - citybiz
CHRN Technical Analysis & Stock Price Forecast - Intellectia AI
ChronoScale names Cenly Chen as chief executive officer By Investing.com - Investing.com South Africa
ChronoScale names Cenly Chen as chief executive officer - Investing.com
ChronoScale Appoints Cenly Chen as Chief Executive Officer to Lead Next Phase of AI Compute Growth - The Manila Times
Ekso Bionics Holdings: Shareholders Board Members Managers and Company Profile | US2826444000 - marketscreener.com
3.37%
0.73%
大文字化:
|
ボリューム (24 時間):